ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,88%
Dow Jones
44 978,61
0,59%
DAX
21 727,20
0,48%
Brent Oil
75,945
0,03%
Bitcoin
105 443,28
1,65%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Evaxion Biotech AS (EVAX) Cours

Evaxion Biotech AS

Evaxion Biotech AS (EVAX)

NASDAQ
2,49
-0,90
( -26,55% )
Mis à jour : 19:36:25
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,49
Prix Achat
2,46
Prix Vente
2,49
Volume échangé
1 118 475
2,35 Fourchette du Jour 2,62
0,00 Plage de 52 semaines 0,00
Cap du marché
6,726M
Clôture Veille
3,39
Ouverture
2,51
Dernière Transaction
8
@
2.49
Dernière heure de transaction
19:36:25
Volume financier
US$ 2 750 315
VWAP
2,459
Volume moyen (3 m)
-
Actions en circulation
2 701 380
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
507k
Bénéfice net
-152,41M

À propos de Evaxion Biotech AS

Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in... Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.evaxion-biotech.com
Siège social
Horsholm, Dnk
Fondé
-
Evaxion Biotech AS est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker EVAX. Le dernier cours de clôture d'Evaxion Biotech AS était de US$3,39. Au cours de la dernière année, les actions de Evaxion Biotech AS ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Evaxion Biotech AS compte actuellement 2 701 380 actions en circulation. La capitalisation boursière d'Evaxion Biotech AS est de US$9,16 million.

EVAX Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

il y a 6 heures
Edgar (US Regulatory)

Evaxion announces pricing of $10.8 million public offering

COPENHAGEN, Denmark, January 30, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced...

il y a 6 heures
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

il y a 14 heures
Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

28 Janvier 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

28 Janvier 2025
Edgar (US Regulatory)

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum equity requirementEvaxion has currently restored...

28 Janvier 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

27 Janvier 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 Janvier 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 Janvier 2025
Edgar (US Regulatory)

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01

Trial remains on track for completion and data readout in the second half of 2025 COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio...

15 Janvier 2025
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

EVAX - Frequently Asked Questions (FAQ)

What is the current Evaxion Biotech AS share price?
The current share price of Evaxion Biotech AS is US$ 2,49
How many Evaxion Biotech AS shares are in issue?
Evaxion Biotech AS has 2 701 380 shares in issue
What is the market cap of Evaxion Biotech AS?
The market capitalisation of Evaxion Biotech AS is USD 9,16M
What is the 1 year trading range for Evaxion Biotech AS share price?
Evaxion Biotech AS has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Evaxion Biotech AS?
Evaxion Biotech AS reports financial results in USD
What is the latest annual turnover for Evaxion Biotech AS?
The latest annual turnover of Evaxion Biotech AS is USD 507k
What is the latest annual profit for Evaxion Biotech AS?
The latest annual profit of Evaxion Biotech AS is USD -152,41M
What is the registered address of Evaxion Biotech AS?
The registered address for Evaxion Biotech AS is DR. NEERGAARDS VEJ 5F, HORSHOLM, 2970
What is the Evaxion Biotech AS website address?
The website address for Evaxion Biotech AS is www.evaxion-biotech.com
Which industry sector does Evaxion Biotech AS operate in?
Evaxion Biotech AS operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FOXXFoxx Development Holdings Inc
US$ 9,71
(235,99%)
25,21M
AMODAlpha Modus Holdings Inc
US$ 3,70
(140,26%)
114,71M
TECXTectonic Therapeutic Inc
US$ 54,79
(113,02%)
4,24M
ACONAclarion Inc
US$ 17,3747
(88,60%)
2,49M
ATHEAlterity Therapeutics Limited
US$ 4,54
(56,01%)
20,38M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2165
(-97,21%)
188,19M
CRGXCARGO Therapeutics Inc
US$ 3,3612
(-74,52%)
17,06M
EVTVEnvirotech Vehicles Inc
US$ 0,3811
(-42,86%)
3,17M
ZKINZK International Group Co Ltd
US$ 0,2952
(-39,20%)
2,12M
FATFAT Brands Inc
US$ 3,5724
(-39,14%)
236,4k
NVDANVIDIA Corporation
US$ 119,675
(-3,25%)
220,97M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2165
(-97,21%)
189,01M
MGOLMGO Global Inc
US$ 0,1249
(22,81%)
146,71M
AMODAlpha Modus Holdings Inc
US$ 3,69
(139,61%)
115,83M
SPGCSacks Parente Golf Inc
US$ 0,87999
(49,15%)
106,96M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
EVAX
Evaxion Biotech AS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces